Chen Qiyu, chairman of Fosun Pharmaceutical and Shanghai Henlius Biotech, did suggest the company may seek a listing on the new tech board in the future. Photo: Jonathan Wong

Fosun biotech unit Henlius has no plans for Shanghai tech board listing and is focused on Hong Kong IPO

  • Hong Kong flotation is our priority, CEO says
Topic |   Fosun Group

TOP PICKS

Chen Qiyu, chairman of Fosun Pharmaceutical and Shanghai Henlius Biotech, did suggest the company may seek a listing on the new tech board in the future. Photo: Jonathan Wong
READ FULL ARTICLE